An evaluation of gemcitabines differential radiosensitising effect in related bladder cancer cell lines

Ítems similars

• Differential radiosensitisation by ZD1839 (Iressa), a highly selective epidermal growth factor receptor tyrosine kinase inhibitor in two related bladder cancer cell lines
  per: Maddineni, S B, et al.
  Publicat: (2005)
• In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients
  per: Mey, V, et al.
  Publicat: (2006)
• Cyclopentenyl cytosine increases gemcitabine radiosensitisation in human pancreatic cancer cells
  per: van Bree, C, et al.
  Publicat: (2008)
• The role of apoptotic cell death in the radiosensitising effect of gemcitabine
  per: Pauwels, B, et al.
  Publicat: (2009)
• The relation between deoxycytidine kinase activity and the radiosensitising effect of gemcitabine in eight different human tumour cell lines
  per: Pauwels, Bea, et al.
  Publicat: (2006)